Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study.

Spyros N DeftereosEvangelos KoutlasEfrosini KoutsourakiAthanassios KyritsisPanagiotis PapathanassopoulosNikolaos FakasVaia TsimourtouNikolaos VlaikidisAntonios TavernarakisKonstantinos VoumvourakisMichalis ArvanitisDimitrios SakellariouFilippo DeLorenzo

Published in: BMC neurology (2018)

Greek registry of non-interventional clinical trials ID: 200136 , date of registration: February 18th, 2013.

Keyphrases

multiple sclerosis
clinical trial
randomized controlled trial
systematic review
dendritic cells
phase ii
metabolic syndrome
open label
phase iii